ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Kidney Diseases

Diabetes trials near Warszawa, Mazowieckie, POL:

GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)

until age 3.00 years to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodie...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Oral Insulin
Other: Placebo

Phase 2

Technical University of Munich

Warsaw, Poland and 6 other locations

months (+ 14 days) to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies i...

Enrolling
Diabetes Mellitus, Type 1
Dietary Supplement: B. infantis
Dietary Supplement: Placebo
Helmholtz Zentrum München

Warsaw, Poland and 7 other locations

Recently updated

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Warsaw, Poland and 58 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Warsaw, Mazowieckie, Poland and 651 other locations

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes...

Enrolling
Diabetes Mellitus, Type 1
Biological: TCD601
Other: Placebo

Phase 2

ITBMed

Warsaw, Poland and 37 other locations

evaluate the efficacy, safety and pharmacokinetic (PK) properties of CPL207280 after multiple (14 days) administration in patients with type 2 diabetes...

Enrolling
Type 2 Diabetes
Drug: Placebo
Drug: CPL207280

Phase 2

Celon Pharma

Kajetany, Nadarzyn, Poland

This study will look at how much weight participants will lose and how much blood sugar control they achieve from the start to the end of the study....

Active, not recruiting
Diabetes Mellitus, Type 2
Obesity
Drug: Placebo
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Poland and 65 other locations

We are doing this study to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. We are doi...

Active, not recruiting
Diabetes Mellitus, Type 2
Chronic Kidney Disease
Drug: Placebo (Semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Poland and 32 other locations

in people with peripheral arterial disease (PAD) and type 2 diabetes. Participants will either get semaglutide or placebo ("dummy") medicine...

Active, not recruiting
Diabetes Mellitus, Type 2
Peripheral Arterial Disease
Drug: Placebo (semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Poland and 124 other locations

in improving blood sugar control in participants with type 2 diabetes (T2D) with inadequate glycemic control using metformin. The study will...

Enrolling
Type 2 Diabetes
Drug: Orforglipron
Drug: Dapagliflozin

Phase 3

Lilly
Lilly

Grojec, Małopolskie, Poland and 77 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems